SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹0.27 | ₹0.21 | ₹0.23 | ₹0.13 | ₹0.13 |
What is the latest Earnings Per Share (EPS) of SYNCOM FORMULATIONS (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹0.27 |
| Mar2024 | ₹0.21 |
| Mar2023 | ₹0.23 |
| Mar2022 | ₹0.13 |
| Mar2017 | ₹0.13 |
How is Earnings Per Share (EPS) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.27 | 28.57 | |
| Mar2024 | ₹0.21 | -8.70 | |
| Mar2023 | ₹0.23 | 76.92 | |
| Mar2022 | ₹0.13 | 0.00 | |
| Mar2017 | ₹0.13 | - | |
Compare Earnings Per Share (EPS) of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,397.8 Cr | -0.3% | -6.8% | -31.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -0.3% |
-6.8% |
-31.1% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses